Cost analysis for CPT G0483 — Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Average Medicare Payment
N/A
Total Payments (Latest)
N/A
Services (Latest)
N/A
Price Change (–)
N/A
The most expensive state pays 1.0x more than the cheapest for this procedure. WI averages $241.98 vs OH at $237.73.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| WI | $241.98 | $201.6K | 833 | 3 |
| MN | $241.98 | $112.8K | 466 | 3 |
| RI | $241.98 | $44.3K | 183 | 4 |
| WV | $241.98 | $28.6K | 118 | 3 |
| ND | $241.82 | $2.7M | 11.3K | 2 |
| CT | $241.78 | $376.4K | 1.6K | 4 |
| NM | $241.75 | $696.5K | 2.9K | 2 |
| NY | $241.74 | $1.5M | 6.1K | 18 |
| LA | $241.70 | $503.0K | 2.1K | 6 |
| MD | $241.64 | $2.0M | 8.5K | 25 |
| MI | $241.62 | $4.7M | 19.6K | 23 |
| GA | $241.59 | $5.9M | 24.4K | 59 |
| IL | $241.55 | $901.2K | 3.7K | 8 |
| SC | $241.53 | $1.3M | 5.4K | 8 |
| AL | $241.52 | $961.0K | 4.0K | 11 |
| DC | $241.41 | $70.3K | 291 | 1 |
| CA | $241.40 | $29.9M | 124.1K | 70 |
| DE | $241.37 | $1.7M | 6.9K | 14 |
| NJ | $241.33 | $5.5M | 22.9K | 41 |
| KY | $241.27 | $4.0M | 16.6K | 41 |
| AZ | $241.23 | $4.3M | 17.9K | 22 |
| MO | $241.19 | $263.6K | 1.1K | 4 |
| PA | $241.14 | $1.8M | 7.3K | 33 |
| FL | $241.06 | $5.5M | 22.7K | 98 |
| VA | $241.05 | $540.4K | 2.2K | 8 |
| MS | $241.04 | $3.3M | 13.9K | 28 |
| OK | $241.02 | $3.5M | 14.5K | 26 |
| OR | $241.01 | $155.5K | 645 | 7 |
| CO | $240.80 | $1.3M | 5.4K | 27 |
| IN | $240.73 | $3.0M | 12.6K | 31 |
| HI | $240.66 | $40.9K | 170 | 2 |
| KS | $240.59 | $745.1K | 3.1K | 3 |
| TN | $240.59 | $12.0M | 49.8K | 66 |
| AR | $240.56 | $712.5K | 3.0K | 15 |
| MA | $240.50 | $475.7K | 2.0K | 9 |
| UT | $240.50 | $1.0M | 4.3K | 19 |
| TX | $240.24 | $14.1M | 58.7K | 166 |
| WA | $240.19 | $1.3M | 5.2K | 18 |
| NV | $239.80 | $1.9M | 7.8K | 25 |
| AK | $239.26 | $115.1K | 481 | 6 |
| NC | $238.47 | $22.7M | 95.2K | 78 |
| OH | $237.73 | $1.0M | 4.3K | 24 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Laboratory Corporation Of America Holdings | Clinical Laboratory | NC | $12.8M | 53.5K | $239.02 |
| Aegis Sciences Corporation | Clinical Laboratory | TN | $9.1M | 37.5K | $241.29 |
| Millennium Health, Llc | Clinical Laboratory | CA | $6.8M | 28.3K | $241.09 |
| Precision Toxicology, Llc | Clinical Laboratory | CA | $6.0M | 24.7K | $241.33 |
| Radeas Llc | Clinical Laboratory | NC | $4.5M | 18.6K | $241.98 |
| Laboratory Corporation Of America Holdings | Clinical Laboratory | NC | $3.3M | 14.4K | $231.02 |
| Medscan Laboratory Inc | Clinical Laboratory | ND | $2.7M | 11.2K | $241.85 |
| Accu Reference Medical Lab, Llc | Clinical Laboratory | NJ | $2.3M | 9.3K | $241.80 |
| Patients Choice Laboratories Of Indiana, Llc | Clinical Laboratory | IN | $2.1M | 8.7K | $241.88 |
| Chabado Genomics Inc | Clinical Laboratory | CA | $2.0M | 8.4K | $241.98 |
| Lifeline Medical Laboratory Incorporated | Clinical Laboratory | CA | $1.9M | 7.7K | $241.98 |
| Gmi Laboratories Llc | Clinical Laboratory | CA | $1.7M | 7.2K | $241.96 |
| Rhb Laboratories Inc | Clinical Laboratory | MI | $1.6M | 6.7K | $241.98 |
| South Georgia Toxicology, Inc | Clinical Laboratory | GA | $1.5M | 6.3K | $241.91 |
| Ethos Holding Corp | Clinical Laboratory | KY | $1.5M | 6.2K | $241.94 |
| Genetic Technological Innovations, Llc | Clinical Laboratory | AZ | $1.5M | 6.1K | $241.98 |
| Certigen Laboratory, Llc | Clinical Laboratory | OK | $1.4M | 5.9K | $241.52 |
| Covenant Laboratories | Clinical Laboratory | MS | $1.3M | 5.5K | $241.98 |
| Equaltox, Llc | Clinical Laboratory | CA | $1.2M | 4.9K | $241.98 |
| Physicians Toxicology Laboratory, Llc | Clinical Laboratory | FL | $1.0M | 4.3K | $241.69 |
Based on the data, CPT G0483 shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.